Thomas Turnage, MD
Clinical Cardiac Electrophysiology · Mobile, ALNPI 1336464676
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $55,125 of the $70,878 with a category attached, or 77.8%. Medical Device Business Services, Inc. accounts for 61.0% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $18,507, 10.0 times the $1,857 reported in 2019.
Across 413 payments — averaging $171.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$43K
- Biosense Webster, Inc.$16K
- Boston Scientific$4K
- Medtronic$3K
- Abbott$958
- Novartis$674
- plus $3K from 25 others
What the payments were for
- Consulting fees$55,12578%
- Travel & lodging$5,2287%
- Food & beverage$10,23014%
- Education$2940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 34 | $43,231 |
| Biosense Webster, Inc. | 55 | $15,625 |
| Boston Scientific | 58 | $4,274 |
| Medtronic(2 entities) | 41 | $2,862 |
| Abbott | 13 | $958 |
| Novartis | 41 | $674 |
| Johnson & Johnson | 47 | $633 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 30 | $559 |
| Pfizer | 21 | $323 |
| Biotronik Inc. | 3 | $282 |
| E.r. Squibb & Sons, L.L.C. | 11 | $185 |
| Siemens Medical Solutions USA, Inc. | 1 | $171 |
| Amgen | 12 | $152 |
| GE HealthCare | 1 | $144 |
| Sanofi-aventis U.S. LLC | 6 | $125 |
| AstraZeneca | 10 | $124 |
| Davol Inc. | 2 | $82 |
| Philips North America LLC | 2 | $70 |
| Esperion Therapeutics, Inc. | 5 | $62 |
| Impulse Dynamics (USA) Inc. | 3 | $58 |
| Atricure, Inc. | 2 | $49 |
| Baxter Healthcare | 1 | $46 |
| Boehringer Ingelheim | 3 | $41 |
| Chiesi USA, Inc. | 2 | $28 |
| Cardiva Medical, Inc. | 1 | $27 |
| Acutus Medical, Inc. | 3 | $23 |
| Irhythm Technologies, Inc. | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Preventice Services, LLC | 1 | $13 |
| Bayer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$57,122
- Micra$1,905
- INGEVITY$1,087
- Carto 3 System$552
- Azure$238
- GENERAL - THERAPIES$224
- ACUSON Origin Diagnostic Ultrasound System$171
- AMPLATZER AMULET$168
- Rivacor 7 DR-T$150
- Edora 8 DR-T$150
- BioMonitor$150
- Acticor 7 VR-T DX$150
- INGEVITY MRI$145
- ENSITE PRECISION$144
- ENSITE$139
- WATCHMAN Access System$132
- Quadra Assura CRT Defibrillator$104
- QDOT MICRO Catheter$104
- VIGILANT$100
How this compares
$70,878 in reported general payments places this provider in the 85th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
See all clinical cardiac electrophysiology providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 818 | $691,006 |
| XareltoRivaroxaban | 242 | $200,622 |
| EntrestoSacubitril/Valsartan | 106 | $103,684 |
| JardianceEmpagliflozin | 24 | $25,307 |
| Flecainide Acetate | 123 | $8,376 |
| Metoprolol Succinate | 416 | $4,700 |
| Amiodarone Hcl | 298 | $4,162 |
| Carvedilol | 226 | $2,444 |
| Sucralfate | 75 | $1,816 |
| Amlodipine Besylate | 221 | $1,565 |
| Atorvastatin Calcium | 118 | $1,528 |
| Losartan Potassium | 77 | $1,142 |
| Dofetilide | 16 | $1,040 |
| ClopidogrelClopidogrel Bisulfate | 91 | $980 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 26 | $868 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $323 | $691,006818 claims |
| Johnson & JohnsonXarelto | $633 | $200,622242 claims |
| NovartisEntresto | $674 | $103,684106 claims |
| Boehringer IngelheimJardiance | $41 | $25,30724 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
Other clinical cardiac electrophysiology in Mobile
- Ernest QuinMobile$65K
- Jordan ChaissonMobile$46K
- Andin MullisMobile$42K
- Robert RobichauxMobile$20K
- Chance WittMobile$14K
- Stephanie GroszMobile$12K
- Noel BedwellMobile$94
- Hugh McElderryBirmingham$725K
- Anil RajendraBirmingham$495K
- Gustavo MoralesBirmingham$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.